ICAR-CMFRI has developed a nutraceutical product from different seaweed species. According to a news release from CMFRI, the seaweed-derived product can treat non-alcoholic fatty liver disease (NAFLD).

Named as Cadalmin LivCure extract, the product is a unique blend of 100 percent natural bioactive ingredients extracted from seaweeds with an eco-friendly green technology to improve liver health.